Mineralys Therapeutics, Inc.

General ticker "MLYS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.7B (TTM average)

Mineralys Therapeutics, Inc. follows the US Stock Market performance with the rate: 42.9%.

Estimated limits based on current volatility of 4.4%: low 25.63$, high 28.00$

Factors to consider:

  • Earnings expected soon, date: 2026-05-11 bmo
  • Total employees count: 12 as of 2022
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [18.76$, 45.00$]
  • 2026-12-31 to 2027-12-31 estimated range: [12.24$, 31.18$]

Financial Metrics affecting the MLYS estimates:

  • Negative: with PPE of -15.6 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -5.71 <= 0.07
  • Negative: negative Net income
  • Negative: negative Industry operating income (median)
  • Negative: Industry earnings per price (median), % of -14.62 <= 0
  • Negative: negative Industry operating cash flow (median)
  • Negative: Shareholder equity ratio, % of 97.72 > 64.25
  • Negative: -0.15 < Industry inventory ratio change (median), % of 0

Similar symbols

Short-term MLYS quotes

Long-term MLYS plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $84.66MM $192.40MM $170.60MM
Operating Income $-84.66MM $-192.40MM $-170.60MM
Non-Operating Income $12.76MM $14.59MM $15.95MM
R&D Expense $70.36MM $168.58MM $132.01MM
Income(Loss) $-71.90MM $-177.81MM $-154.65MM
Profit(Loss)* $-71.90MM $-177.81MM $-154.65MM
Stockholders Equity $241.15MM $191.26MM $646.69MM
Assets $251.64MM $205.90MM $661.81MM
Operating Cash Flow $-81.17MM $-166.31MM $-142.42MM
Capital expenditure $0.00MM $0.10MM $0.01MM
Investing Cash Flow $-160.47MM $114.96MM $-389.75MM
Financing Cash Flow $203.25MM $116.14MM $591.00MM
Earnings Per Share** $-1.99 $-3.66 $-2.29

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.